Form D Explorer

Form C-AR — Aspire BioPharma Inc.

0001493152-24-016259 · filed 2024-04-26

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Aspire BioPharma Inc.
CIK: 1995528
Entity: Corporation
Jurisdiction: PR
Address: 194 Candelaro Drive
Humacao, PR 00791
Phone: —

Most recent fiscal year financials

Total assets

$5,017,181

Cash

—

Short-term debt

$652,490

Long-term debt

$3,852,552

Revenues

—

COGS

—

Taxes paid

—

Net income

$-359,071

View original on SEC EDGAR.